Plain-English translation of NCT06706700 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Pancreatic cysts are common and usually harmless, but some can turn into cancer over time. This study is searching for new biological markers—measurable signs in your blood and imaging scans—that can help doctors identify which cysts are truly dangerous and which ones are safe to leave alone. By finding better ways to spot the risky cysts, doctors hope to avoid unnecessary surgery in patients who don't need it.
Currently, doctors don't have reliable blood tests to tell the difference between benign (harmless) cysts and dangerous ones, which leads to some patients having surgery they may not have needed. This study aims to fill that gap by identifying new markers that can predict which cysts will progress to cancer.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would either participate in the retrospective part (where researchers review your past medical records and surgery results if you had surgery between 2009 and 2018) or the prospective part (where you would donate blood samples and allow researchers to review your imaging scans and medical information before and after any surgery). The study is collecting information from up to 586 patients total to identify patterns that help predict which cysts are dangerous.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Italy